Use of an 8132 Asymmetrical Factorial Design for the in Vitro Evaluation of Ondansetron Permeation Through Human Epidermis

Pharmaceutical Development and Technology

Volumn 9, Issue 1, 2004, Pages 39-48

  Dimas, Dimitrios A ^a   Dallas, Paraskevas P ^a   Rekkas, Dimitrios M ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Asymmetrical factorial design; Ondansetron; Penetration enhancers; Transdermal

Indexed keywords

1 METHYL 2 PYRROLIDINONE; CINEOLE; GLYCEROL OLEATE; HYDROXYPROPYLCELLULOSE; LAURIC ACID; LAUROCAPRAM; LAURYL ALCOHOL; MYVEROL 19 99; OLEIC ACID; OLEYL ALCOHOL; ONDANSETRON; PENETRATION ENHANCING AGENT;

ARTICLE; ASYMMETRICAL FACTORIAL DESIGN; CADAVER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; DRUG MIXTURE; DRUG PENETRATION; DRUG POTENTIATION; DRUG RELEASE; DRUG SOLUBILITY; EPIDERMIS; FACTORIAL ANALYSIS; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SKIN PERMEABILITY; STEADY STATE;

DIFFUSION CHAMBERS, CULTURE; DRUG EVALUATION, PRECLINICAL; EPIDERMIS; HUMANS; ONDANSETRON; PERMEABILITY; RESEARCH DESIGN; SKIN ABSORPTION; TISSUE DONORS;

EID: 1342301735     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120027416     Document Type: Article

References (34)

1. Llacer, J.M.; Gallardo, V.; Parera, A.; Ruiz, M.A. Formation of ondansetron polymorphs. Int. J. Pharm. 1999, 177, 221-229.
2. Roila, F.; Favero, D.A. Ondansetron clinical pharmacokinetics. Clin. Pharmacokinet. 1995, 29 (2), 95-109.
3. Simpson, K.H.; Hicks, F.M. Clinical pharmacokinetics of ondansetron. A review. J. Pharm. Pharmacol. 1996, 48, 774-781.
4. Cothhup, P.V.; Felgate, C.C.; Palmer, J.L.; Scully, N.L. Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly. J. Pharm. Sci. 1991, 80 (9), 868-871.
5. Llacer, J.M.; Ruiz, M.A.; Parera, A.; Gallardo, V. Adsortion-desorption of ondansetron on latex particles. Drug Dev. Ind. Pharm. 2000, 26 (3), 237-242.
6. www.fda.gov/medwatch/safety/2000/dec00.htm, (accessed July 2002)
7. Anderson, P.O.; Knoben, J.E.; Troutman, W.G. Handbook of Clinical Drug Data; Appleton & Lange: Connecticut, 1999; 519 pp.
8. Micromedex. Thomson Healthcare; Thomson Healthcare, 2001; Vol. 109, 3rd Quarter.
9. Pfister, W.R.; Hsieh, D.S.T. Permeation enhancers compatible with transdermal drug delivery systems part I: selection and formulation considerations. Pharm. Technol. 1990, 14 (9), 132-139.
10. The Merck Index on CD-ROM, v. 12:2; Merck & Co.: Whitehouse State, NJ, 1997.
11. The United States Pharmacopeia 24; United States Pharmacopeial Convention: Rockville, MD, 2000; 1218-1220.
12. Takahashi, K.; Rytting, J.H. Approach to improve permeation of ondansetron across shed snake skin as a model membrane. J. Pharm. Pharmacol. 2001, 53, 789-794.
13. Giannakou, S.A.; Dallas, P.P.; Rekkas, D.M.; Choulis, N.H. Development and in vitro evaluation of nimodipine transdermal formulations using factorial design. Pharm. Dev. Technol. 1998, 3 (4), 517-525.
14. Klingman, A.M.; Christophers, E. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 1963, 88, 702-709.
15. Bolton, S. Pharmaceutical Statistics; Marcel Dekker, Inc.: New York, 1984; 258-280.
16. Montgomery, D.C. Introduction to Statistical Quality Control, 3rd Ed.; John Wiley & Sons, Inc.: New York, 1997; 512-571.
17. Montgomery, D.C. Design and Analysis of Experiments, 4th Ed.; John Wiley & Sons, Inc.: New York, 1997; 228-280.
18. Lewis, G.A.; Mathieu, D.; Phan-Tan-Luu, R. Pharmaceutical Experimental Design; Marcel Dekker, Inc.: New York, 1999; 23-76.
19. Voinovich, D.; Campisi, B.; Moneghini, M.; Vincezi, C.; Phan-Tan-Luu, R. Screeening of high shear mixer melt granulation process variables using an asymmetrical factorial design. Int. J. Pharm. 1999, 190, 73-81.
20. El-Kattan, A.F.; Asbill, C.S.; Kim, N.; Michniak, B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 2001, 215, 229-240.
21. Walters, K.A.; Hadgraft, J. Pharmaceutical Skin Penetration Enhancement; Marcel Dekker, Inc.: New York, 1993.
22. Gwak, H.S.; Chun, I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 2002, 236, 57-64.
23. Barry, B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 2001, 14, 101-114.
24. Barry, B.W. Lipid-protein-partitioning theory of skin penetration enhancement. J. Control. Release 1991, 15, 237-248.
25. Shin, S.C.; Kim, J.; Yoon, M.K.; Oh, I.J.; Choi, J.S. Transdermal delivery of triprolidine using TPX polymer membrane. Int. J. Pharm. 2002, 235, 141-147.
26. Monti, D.; Giannelli, R.; Chetoni, P.; Burgalassi, S. Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro. Int. J. Pharm. 2001, 229, 131-137.
27. Gabiga, H.; Cal, K.; Janicki, S. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Int. J. Pharm. 2000, 199, 1-6.
28. Francoeur, M.L.; Golden, G.M.; Potts, R.O. Oleic acid: its effect on the stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 1990, 7, 621-627.
29. Walker, M.; Hadgraft, J. Oleic acid - a membrane fluidizer or fluid within the membrane? Int. J. Pharm. 1991, 71, R1-R4.
30. Kanikkannan, N.; Kandimalla, K.; Singh, M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 2000, 7, 593-608.
31. Andega, S.; Kanikkannan, N.; Singh, M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control. Release 2001, 77, 17-25.
32. Hadgraft, J.; Williams, D.C.; Allan, G. Azone: mechanisms of action and clinical effect. In Pharmaceutical Skin Penetration Enhancement; Walters, K.A., Hadgraft, J., Eds.; Marcel Dekker, Inc.: New York, 1993; 175-197.
33. Bach, M.; Lippold, B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 1998, 46, 1-13.
34. Cleary, G.W. Transdermal drug delivery. Cosmet. Toiletries 1991, 106, 97-109.